Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle
- PMID: 1527732
Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle
Abstract
Sodium nitroprusside (SNP) is thought to exert its vasodilating activity, at least in part, by vascular activation to nitric oxide (NO), but the activation mechanism has not been delineated. This study has examined the potential for vascular metabolism of SNP to NO in bovine coronary arterial smooth muscle subcellular fractions using a sensitive and specific redox-chemiluminescence assay for NO. SNP was readily metabolized to NO in subcellular fractions, and the dominant site of metabolism appeared to be located in the membrane fractions. NO-generating activity was significantly enhanced by, but did not absolutely require, the addition of a NADPH-regenerating system, NADPH per se, NADH or cysteine. A correlation analysis of NO-generating activity (in the presence of a NADPH-regenerating system) with marker enzyme activities indicated that the SNP-directed NO-generating activity was primarily membrane-associated. Radiation inactivation target-size analysis revealed that the microsomal SNP-directed NO-generating activity was relatively insensitive to inactivation by radiation exposure, suggesting that the functioning catalytic unit might be quite small. A molecular weight of 5 to 11 kDa was estimated. NO-generating activity could be solubilized from the crude microsomes with 3-[(3-cholamidopropyl)- dimethylammonio]-1-propane sulfonate, and the solubilized extract was subjected to gel filtration chromatography. NO-generating activity was eluted in two peaks: one peak corresponding to an approximate molecular weight of 4 kDa, thus confirming the existence of a small molecular weight NO-generating activity, and a second activity peak corresponding to a molecular weight of 112 to 169 kDa, the functional significance of which is unclear at present.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Vascular nitric oxide-generating activities for organic nitrites and organic nitrates are distinct.J Pharmacol Exp Ther. 1991 Nov;259(2):519-25. J Pharmacol Exp Ther. 1991. PMID: 1682477
-
Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells.J Pharmacol Exp Ther. 1990 May;253(2):614-9. J Pharmacol Exp Ther. 1990. PMID: 2110975
-
Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.J Pharmacol Exp Ther. 1992 Feb;260(2):652-9. J Pharmacol Exp Ther. 1992. PMID: 1738115
-
Endothelial nitric oxide generating enzyme(s) in the bovine aorta: subcellular location and metabolic characterization.J Pharmacol Exp Ther. 1990 Apr;253(1):20-6. J Pharmacol Exp Ther. 1990. PMID: 2329507
-
Nitric oxide generation from pharmacological nitric oxide donors.Methods Enzymol. 1996;268:259-65. doi: 10.1016/s0076-6879(96)68028-8. Methods Enzymol. 1996. PMID: 8782592 Review. No abstract available.
Cited by
-
Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery.Br J Pharmacol. 2000 Oct;131(3):521-9. doi: 10.1038/sj.bjp.0703588. Br J Pharmacol. 2000. PMID: 11015303 Free PMC article.
-
Growth inhibition and radiosensitization of cultured glioma cells by nitric oxide generating agents.J Neurooncol. 1999 Mar;42(1):35-44. doi: 10.1023/a:1006160305294. J Neurooncol. 1999. PMID: 10360477
-
MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries.J Pharmacol Exp Ther. 2011 Jan;336(1):127-33. doi: 10.1124/jpet.110.174482. Epub 2010 Oct 19. J Pharmacol Exp Ther. 2011. PMID: 20959363 Free PMC article.
-
Role of cyclic GMP on inhibition by nitric oxide donors of human eosinophil chemotaxis in vitro.Br J Pharmacol. 2004 Feb;141(4):653-60. doi: 10.1038/sj.bjp.0705661. Epub 2004 Jan 26. Br J Pharmacol. 2004. PMID: 14744805 Free PMC article.
-
Role of endothelium in the human uterine arteries during normal menstrual cycle.Br J Pharmacol. 1995 Feb;114(4):902-8. doi: 10.1111/j.1476-5381.1995.tb13289.x. Br J Pharmacol. 1995. PMID: 7773552 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources